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ABSTRACT
Reduced GABAergic signaling at the axon initial segment decreases vigilance
state transitioning
by
Austin John Boren
Dr. Rochelle Hines, Examination Committee Chair
Assistant Professor of Psychology
University of Nevada, Las Vegas
Sleep is a highly regulated homeostatic process that is disrupted in an estimated
50-70 million Americans. Regulation of sleep depends upon coordinated signaling of
multiple neurotransmitter systems. In particular, inhibitory gamma-aminobutyric acid
(GABA) signaling is required to suppress wake-active brain regions in order to initiate
and maintain sleep states. GABA type A receptors (GABAARs) are ionotropic receptors
with subunit compositions uniquely enriched on subcellular domains of target cells. α2
subunit-containing GABAARs are the primary target of GABA released onto the axon
initial segment (AIS), a site critical for phasing the oscillatory activity of cortical cells. α2containing GABAARs have previously been implicated in the initiation and maintenance
of sleep. To determine the contribution of GABAergic singling at the AIS to regulation of
sleep, we used behavioral and electroencephalographic measures to assess sleep in a
mouse featuring a loss of inhibitory synapses onto the AIS (Gabra2-1). Reduced
GABAergic input to the AIS results in a persistent increase in the delta frequency range
in Gabra2-1 mice, suggesting an alteration in sleep regulation. Analysis of long term
recordings demonstrate that Gabra2-1 homozygous mice spend less time asleep during
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subjective night, and also have reduced vigilance state transitions. Gabra2-1
homozygous mice show a loss of free running rhythm when housed in constant
darkness, and fail to homeostatically respond to 24 hours of sleep deprivation. These
studies demonstrate a role for α2 containing GABAARs in sleep initiation, transitions,
and the response to sleep challenges, providing critical information for the refinement of
sleep therapies.
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CHAPTER 1
INTRODUCTION
The central nervous system (CNS) oscillates at multiple timescales allowing for
temporal patterning of complex behavior. The cyclic patterning of sleep is considered to
be a master oscillatory pattern as it regulates many homeostatic functions1. Disruptions
to its progression results in primary sleep disorders impacting 50-70 million Americans
while sleep disturbances are a common symptom of CNS disorders2,3. Homeostatic
regulation of sleep depends on the establishment and maintenance of oscillatory
patterns occurring on relatively long time scales, including the circadian rhythm. In
humans, the circadian rhythm is an oscillation taking about 24 hours that determines the
timing of sleep 4. Misalignment of the circadian rhythm to the natural light/dark cycle
results in circadian rhythm disorders5. While the circadian rhythm regulates the timing of
the sleep/wake cycle, a shorter 90-mintue oscillation, the basic rest activity cycle
(BRAC)6, further regulates the time in which we are sleeping, delimiting the known sleep
stages. Determined by the predominate electroencephalographic (EEG) signal present,
sleep is divided into non-rapid-eye-movement (NR) and rapid-eye-movement sleep (R).
NR sleep, consuming about 75% of our sleeping hours, is dominated by the presence of
slow wave activity in the delta frequency range (0.5-4.0 Hz) representing large, highly
synchronized networks of neurons 7. In contrast R, taking up about 25% of our sleeping
hours, is dominated by a high delta/theta ratio along with the presence of gamma (30100Hz) which is associated with network activity, allowing for dreams 8. The
establishment and maintenance of oscillatory patterns essential to sleep regulation
depends on GABAergic signaling inhibiting wake-promoting regions9 at appropriate
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times. There are several lines of evidence suggesting a pivotal role for GABAergic
signaling in sleep onset and maintenance with the first coming from the discovery of
sleep inducing drugs. Many sleep drugs were discovered without knowing their
functional properties, yet later it came to light that the majority of them acted by
increasing the affinity of gamma-aminobutyric-acid (GABA) to GABA receptors10.
Further, when specific GABA receptor subtypes are render insensitive by point
mutation, these compounds they lose their sedative qualities11,12. Lastly, it is found that
increased GABAergic signaling in distinct brain regions either promotes or reduces
sleep10,13. Taken together, these studies suggest a central role for GABA and GABA
receptors in sleep and sleep regulation.
A large body of work has since demonstrated that GABAergic neurotransmission
is diverse in terms of cellular origin, postsynaptic subcellular target, and molecular
composition, giving rise to diverse functional implications14–16. One key role of
GABAergic singling is the patterning of excitatory output into oscillatory states, that
support specific behavioral states, including active and relaxed waking, as well as
stages of sleep17,18. The potential to control oscillatory activity is particularly true of
GABAergic contacts on the soma and axon initial segment (AIS) that exert powerful
control over pyramidal cell activity by virtue of proximity to the site of action potential
generation19.
The primary target of synaptically released GABA is the ionotropic GABA type A
receptor (GABAARs)20. Each GABAAR contains a combination of five out of 19 possible
subunits: α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ⍴(1-3), resulting in 26 known human
isoforms14. The majority of functional GABAARs expressed in the brain are composed of
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two α, two β, and one γ subunit21. Although subunit composition is relatively uniform
amongst GABAARs, the specific subunit composition plays a significant role in
determining function. α subunits are thought to be important determinants of localization
and consequent function, with α1-3 subunits being enriched in receptors clustered at
specific postsynaptic targets, and α4-6 enriched in extra synaptic receptors21. GABAARs
containing the α1 subunit are found to be enriched at axo-somatic synapses
postsynaptic to parvalbumin positive basket cells 22 while α2/3 containing GABAARs are
enriched postsynaptic to cholecystokinin-expressing positive basket cells15,23. α2
containing GABAARs are also notably enriched along the AIS, postsynaptic to
parvalbumin positive chandelier cells24–26, a site thought to play a pivotal role in shaping
excitatory output27.
The advent and subsequent study of subunit selective sleep compounds
suggests GABAARs containing the α2 subunit may be central to sleep regulation.
Classic sleep agents such as diazepam are non-selective as they act on all
benzodiazepine sensitive GABAARs including receptors containing the α1, α2, α3, or α5
subunit28. Interestingly, the α1/α2 selective compound zolpidem (Ambien) action alone
is sufficient for inducing certain aspects of sleep. Specifically, zolpidem decreases sleep
latency and increases sleep time29,30. In addition, selective application of zolpidem in the
tuberomammillary nucleus is sufficient for the effects of zolpidem on sleep latency, and
zolpidem application in the frontal cortex can reduce sleep latency in a top down
fashion30. Further, expression of the GABAAR containing the α2 subunit has been
documented in hypothalamic and pontine regions31, including on histaminergic neurons
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of the tuberomammillary nucleus32,33 yet its precise role in sleep regulation is yet to be
demonstrated.
Previous work has identified a 13 amino acid sequence within the large
intracellular loop of the GABAAR α2 subunit that is essential for trafficking to the AIS34.
Our recent study showed that the α1/3 and α2 loops have complementary interaction
strengths with gephyrin and collybistin, with the α2 loop and collybistin SH3 domain
having a unique high affinity interaction35. Based on the indication of the α2 loop in
collybistin interaction and AIS localization, we generated and characterized a novel
strain, Gabra2-1, that expresses a 13 amino acid substitution from the α1 subunit into
the α2 subunit large intracellular loop(Figure 1 A)35. Total expression of α2 was
increased in the cortex of Gabra2-1 mice, but collybistin was dramatically reduced
(Figure 1 B). Assessment of inhibitory synapses targeting the axon initial segment
revealed a loss of α2 enrichment and VGAT positive contacts (Figure 1C)35.
In the present study we use Gabra2-1 mice as a tool to probe the functional
impact of AIS GABAergic signaling in oscillatory activity and behavioral output, focusing
on sleep architecture, homeostasis, and the response to sleep challenges. We
demonstrate that reduced α2 signaling at the AIS in Gabra2-1 homozygous mice results
in a striking increase in baseline EEG power that is maintained across the 24 hour
period. Spectral analysis demonstrates that the increase in EEG power is restricted to
the delta frequency ranges during the vigilance state of NREM sleep. Interestingly, this
manifests as a reduction in time spent asleep during subjective night. Further, Gabra2-1
homozygous mice also show reduced transitions into and out of specific stages of
sleep. Gabra2-1 homozygous mice also have altered responses to sleep challenges,
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including an inability to maintain free running circadian rhythmicity in the absence of
light as a zeitgeber, and a blunted homeostatic response to sleep deprivation.
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CHAPTER 2
REVIEW OF RELATED LITRATURE
Inhibition, γ-aminobutyric acid and γ-aminobutyric acid receptors
First localized at nerve terminals in the 1970’s using radioactive labelling and
complementary electron microscope autoradiography techniques, GABA was
recognized as the primary inhibitory neurotransmitter of the CNS36. This
neurotransmitter is produced by two enzymatic reactions, GAD65 and GAD67 acting on
glutamate37. The resulting GABA neurotransmitter is loaded into synaptic vesicles by
vesicular neurotransmitter transporter (VGAT) and is then ready to be released into the
synaptic cleft by presynaptic Ca2+ signaling.
Once GABA is released into the synaptic cleft it can act upon ionotropic as well
as metabotropic GABA receptors. Discovered by professor Norman Bowery in 198138,
metabotropic G-protein-coupled γ-aminobutyric acid, B-type (GABAB) receptors, found
both pre- and post-synaptically, are responsible for the tonic inhibitory action of GABA.
GABAB receptors take relatively more time than other GABA receptors to act due to the
time it takes for G-protein-coupled receptors to activate the necessary components of
the pathway and effect downstream inhibition. When GABA binds to GABAB in
presynaptic receptors it inhibits presynaptic Ca2+ channels effectively reducing
neurotransmitter release while activation of postsynaptic GABAB receptors acts on
several inward rectifying K+ channels hyperpolarizing neurons and shunting excitatory
input39,40. Although mutations to GABAB receptors are implicated in disease states, it is
the phasic form of inhibition and its associated receptor type that is implicated in sleep
disorders.

6

GABAARs are the primary source of phasic inhibition in the adult CNS. GABAARs
have active binding sites for psychoactive drugs including benzodiazepines,
barbiturates, steroids, anesthetics, and anticonvulsants41. GABAARs are
heteropentameric ligand gated ion channels allowing Cl- to pass through the central
canal when activated. Each GABAAR is constructed from a combination of five subunits
including α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ⍴(1-3)42 with 26 human isoforms being
identified thus far42.
Signaling properties, localization, and expression of GABAARs is determined by
subunit composition. When considered globally, GABAARs containing α1, β2, and γ2
subunits are the most highly expressed across all brain regions42. Regionally, receptors
containing α1, β1, β2, and β3 subunits are homogenously expressed while receptors
containing α2, α3, α4, α5, α6, γ1 and δ subunits are found to be heterogeneously
expressed, primarily in the forebrain areas41. Allowing for precise spatial and temporal
modulation of excitatory signaling, GABAARs are also differentially expressed at
subcellular locations postsynaptic to specific interneurons synapsing on dendrites,
axons, and the cell body15. Receptors containing the α1 subunit are found at most
GABAergic synapses with the highest concentration at inhibitory synapses on dendrites
and soma postsynaptic to parvalbumin positive basket cells25. Receptors containing the
α2 subunit, more limited in their expression, are found to be enriched postsynaptic to
chandelier cells synapsing at the AIS43. Analysis of subunit concentration at the synaptic
level has shown that GABAARs found at extra-synaptic sites generally contain α4 or α6
subunits while receptors found at synaptic sites generally contain α1, α2, or α344,45.
Given the highly specialized nature of GABAARs distribution, altered inhibitory
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localization and expression is thought to underlie diseases of neuronal dysregulation,
highlighting the importance of discovering the signaling molecules and proteins involved
in their trafficking and expression46.
Several receptor-associated, adhesion, and scaffolding proteins are suspected to
interact with GABAARs subtypes in unique ways allowing for differential expression and
localization. Although the full signaling pathway for trafficking of all GABAARs subtypes
has yet to be discovered, a few key proteins have been identified as central to this
process. Gephyrin, a scaffolding protein necessary for the clustering of several receptor
types including glycine receptors is found to be highly co-localized with GABAARs47,48.
The Moss lab has demonstrated binding motifs on GABAARs containing α1, α2, and α3
subunits for gephyrin necessary for appropriate receptor clustering49–51. Recent work
from the Moss lab demonstrates the necessity of another scaffolding protein, collybistin,
in the trafficking and clustering of GABAARs containing the α2 subunit onto the AIS35.
In the present study we aim to determine the contribution of GABAARs containing the α2
subunit at the AIS to the phenomena of sleep, as this synaptic sight, discussed in the
next section, is thought to be central to network functioning.

The axon initial segment
Excitatory principal neurons are the fundamental cells of neuronal
communication in the CNS. These specialized cells have an atypical structure, one of
asymmetry, endowing them with specialized communication properties. First proposed
by Santiago Ramon y Cajal, along with the neuron doctrine, the law of dynamic
polarization states that information flows along the principal neuron in only one
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direction, driven by cellular polarization52,53. Under this paradigm, the neuron can be
seen as a simple input-output device. The dendrites act as an input device, sensing a
signal in the form of a chemical messenger from up-stream neurons. This signal is then
transduced to the cell body. If polarity is sufficiently shifted, an action potential (AP) is
fired, the signal is then transduced along the axon where the terminal buttons act as an
output device. This stroke of insight by Cajal inspired generations of biologist to study
and define the cellular structures, receptors, and chemical messengers underlying this
fundamental principal of neuronal communication.
In landmark experiments conducted by Hodgkins and Huxley on the signaling
properties of the giant squid axon, they described the principal electrical component of
neuronal communication, namely the AP54. The ‘decision point’ determining if an AP is
fired occurs in a specialized subcellular compartment found just distal of the axon hillock
and ending at the first section of myelination, the AIS43. Similar to the nodes of Ranvier,
the AIS is studded with ion channels allowing for rapid depolarization and repolarization.
Three forms of Na+ channels are highly enriched on the AIS including Nav1.155,
Nav1.256, and Nav1.657 allowing for rapid depolarization and AP initiation. K+ channels
including Kv1.1 and 1.2 are enriched at the AIS for rapid repolarization58.
Modulation of AP’s occurs via GABAergic interneurons synapsing at the AIS.
Specifically, the chandelier cell with its striking morphology of highly branched axonal
arbors are found to synapse exclusively at the AIS59,60. These specialized interneurons
are thought to contribute to the generation of neuronal networks as their highly
branched arbors reach out and synapse with hundreds of principal cells61 at the AIS
allowing them to effectively modulate the timing of AP’s across neuronal networks62. Of
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interest to the current study, chandelier cells, or axo-axonic cells, are found to have a
high postsynaptic density of GABAARs containing the α2 subunit suggesting this GABAA
receptor subtype may be central to network functioning62.
Given the significant role the AIS, axo-axonic cells, and GABAARs containing the
α2 subunit play in network functioning, disruptions to these processes are thought to
underlie common disorders of the CNS. It has been demonstrated that axo-axonic
synapses are reduced at the epileptic foci63 and are thought to underlie continued
dysregulated excitation in epilepsies. Further, altered axo-axonic innervation and α2
distribution are thought to disrupt the excitatory to inhibitory ‘balance’64 and contribute to
schizophrenia and neurodevelopmental disorders including autism spectrum65,66. The
full contribution of altered AIS morphology, axo-axonic cell synapsis, and distribution of
GABAARs containing the α2 subunit to these common disorders is still an open scientific
question.
Very little is known about the contribution of the AIS and axo-axonic cells to the
processes of sleep. Sleep is dependent and defined by specific oscillatory activity
discussed in the next section. Given the role axo-axonic cells play in patterning
pyramidal output into oscillatory activity, it is likely their signaling properties contribute to
various oscillations of sleep. In a study conducted by Massi et. al., in 2012 they suggest
axo-axonic cells and basket cells may contribute to NREM and REM sleep oscillations,
including spindle and gamma oscillations67. It is part of the aim of this study to
determine the impact of a loss of GABAARs containing the α2 subunit at the AIS to
sleep and its natural oscillatory progression.
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GABAergic contribution to sleep, circadian, and ultradian rhythms
The circadian rhythm is an oscillation taking about 24 hours in humans that
entrains the biological system to the environment allowing for timely behavioral output.
In an elegant paper published by Aschoff in 1965, he observed circadian rhythmicity in
humans under deprived conditions to understand the role of environmental input, or
zeitgebers, on its cyclic duration or τ. He placed participants (including himself) in an
environment lacking all zeitgebers and found that the τ of a free-running circadian
rhythm in humans is an average of 25.9 hours68. Further, he described the impact of
desynchronization, the mismatch between sleep and circadian rhythmicity, and its
impact on psychological well-being. Subjects reported more positively on days in which
these processes were aligned. A landmark paper published in 1982 by Borbely A.A.
further refined our understating of the circadian rhythm and how it interacts with sleep.
In this paper titled the ‘Two process-model of sleep regulation’ it is proposed that the
sleep/wake cycle (Process S) and the circadian pacemaker (Processes C) oscillate at
different timescales, yet interact to define sleep wake activity. In summary it is
suggested that Processes S is driven by increased sleep pressure caused by prior
wakefulness and that it is entrained to the light dark cycle by Process C4. This model is
still used today to study how Process S and C interact. Process S is established by
sleep pressure which is assessed by EEG slow wave activity (SWA). Many EEG studies
have shown that SWA, the hallmark of ‘restorative’ sleep, is modulated by prior
wakefulness69–71 with increased prior wakefulness resulting in higher levels of SWA.
These data suggest that accumulation and dissipation of sleep pressure contribute to
the cyclic nature of Process S. Process C is established by a complex feedback system
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taking place in the suprachiasmatic nucleus which interacts with the zeitgeber light72
The progression of Process C is assessed by levels of melatonin and core body
temperature, with high levels of melatonin and reduced core body temperature
indicating a higher probability of sleep initiation73. Described by Nathaniel Kleitman in
1963 by studying infant feeding patterns, the sleep/wake cycle is further modulated by
the basic rest activity cycle (BRAC)74. The BRAC is an ultradian rhythm (a cycle less
than a day and greater than an hour) that determines our activity level while awake and
drives the progression of sleep stages while asleep6. That is the progression from nonrapid-eye-movement (NREM) to rapid-eye-movement sleep (REM), occurring 6-9 times
a night. The interaction of these exogenously and endogenously generated cycles allow
for appropriate behaviors responses at appropriate times.
Driven by these early studies, biologists have worked to understand the regions
of the brain and neuronal progenitors of sleep. Sleep is a brain-wide process with a few
key areas and neuronal types contributing to its onset and maintenance. The
hypothalamus houses most of the regions thought to control vigilance, projecting their
signal across the cortex to promote wakefulness or being suppressed to induce sleep.
Within the hypothalamus, the ventrolateral preoptic nucleus (VLPO) projects onto the
tuberomammillary nucleus (TMN). The VLPO houses GABAergic neurons which
increase their firing rate at sleep onset75. The TMN houses histaminergic neurons,
which when inhibited by the VLPO no longer release histamine, a wake promoting
neurotransmitter, across the cortex allowing for sleep10. Other areas including the
pedunculopontine and laterodorsal tegmental nuclei, housing cholinergic neurons,
which act via another wake promoting neurotransmitter acetylcholine, are found to be
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inhibited during sleep as they have been shown to be inactive during times of NREM76.
Other distributed regions work in concert with the VLPO to inhibit wake promoting areas
allowing humans to fall asleep in mere minutes. This observation led to Saper’s ‘flip-flop’
model of sleep onset77. This model suggests reciprocal inhibition from several sleep
promoting areas creates an integrated network that can be turned off rapidly for quick
vigilance state transitions.
Given that all of the above mentioned processes depend on GABAergic
inhibition, it has long been a challenge to discover the contribution of GABAAR subtypes
to sleep. Classic sleep drugs including benzodiazepines are positive allosteric
modulators, increasing GABA’s action on GABAARs, inducing sedation and sleep.
Although the action of these classic sleep compounds indicates that GABAergic
signaling is central to sleep, they do not inform us about receptor subtype contribution
as they act on all benzodiazepine sensitive GABAAR including α1, α2, α3, and α528. The
discovery of selective sleep compounds has begun to reveal the specific contribution of
GABAARs subunits to sleep. The α1/α2 selective compound Zolpidem (Ambien) is the
most prescribe sleep medication in the United States. This drug is known to decrease
sleep latency and increase NREM time78. Clarifying the action of zolpidem, studies have
shown an enrichment of GABAARs containing the α1/α2 subunit in the TMN79,80.
Further, an electrophysiological study from Sergeeva’s lab demonstrated the necessary
action of α1/α2 in the TMN for the action of benzodiazepines81. Given the selective
action of zolpidem, evidence that GABAARs containing the α2 subunit are enriched in
the TMN, and that they contribute significantly to benzodiazepine’s action in the TMN,
we are currently using IHC to investigate the colocalization of α2 with histaminergic
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neurons in the TMN as this may be mechanistic to sleep disturbances observed in the
Gabra2-1 mouse model.
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CHAPTER 3
MATERIALS AND METHODS
Subjects
Male mice bread at UNLV were group housed under a 12 hour light cycle (0700;
lights on), constant temperature, and access to food and water ad libitum. All animal
studies were performed under protocols approved by the Institutional Animal Care and
Use Committee of University of Nevada Las Vegas.

Genetic strategy
The Gabra2-1 mouse was generated by substitution of amino acids 358-375 from
the large intracellular loop spanning transmembrane 3 and 4 of the GABAARs
containing the α2 subunit with those of GABAARs containing the α1 subunit using
homologous recombination in ES cells (Figure 1 A). Offspring were probed for the
transgene using PCR with primers spanning the intronic region containing the remaining
loxP site(SI Figure 1 A). Nontransgenic litter mates were used as controls in all
experiments.

Western blotting
Rapidly harvested whole brain tissue was homogenized in TEEN buffer (50mM
Tris-HCL, 1mM EGTA, 150mM NaCl) with the addition of a protease inhibitor from
Roche Applied Science. Resulting protein concentration was determined by BCA assay
(Pierce). In preparation for blotting, samples were heated to 65°C in SDS page sample
buffer with 10% ß-mercaptoethanol for 15 minutes and subject to SDS page
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procedures. Resulting western blot signal were detected using ECL. Quantification of
specific protein levels were determined by densitometry when normalized to actin
densitometry results utilizing image J software.

Immunohistochemistry
For histology, mice were transcardially perfused with periodate lysine
paraformaldehyde (PFA) fixative solution. Following PFA fixation, brains were sectioned
at the thickness of 30um with a cryostat and incubated in blocking solution (2.5%
Bovine Serum Albumin, 5% Normal Goat Serum, 0.1% triton-X, 0.02% sodium azide in
PBS) for 45 minutes. Sections were then incubated in primary antibody diluted in
modified blocking solution (2% Normal Goat Serum) overnight at 4°C. Following
washing, sections were then incubated in secondary antibody diluted in modified
blocking solution for 1 hour at room temperature.

Electroencephalographic surgery and data collection
Mice were implanted with chronic electroencephalographic (EEG) devices under
isoflurane anesthesia. Two cortical EEG electrodes (stainless-steel screws) were placed
in the frontal and parietal areas. Reference and ground electrodes are placed caudally.
EMG electrodes were placed bilaterally in the dorsal nuchal musculature. All electrodes
were soldered to an EEG/EMG headmount (Pinnacle Technology) which was then
anchored to the EEG, reference, and ground electrodes with dental cement. The mice
were sutured, given a bolus of lactated ringer solution, individually housed, and
monitored for pain during recovery. 48 hours prior to data collection mice were
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habituated to circular Plexiglas recording chambers (Pinnacle Technology) with a
preamplifier connecting the chronic headmounts to a data acquisition device (Pinnacle
Technology) via a micro-connector. During data collection, the electrical signal was
acquired and stored for later offline analysis by a computer-based system using Sirena
Acquisition software (Pinnacle Technology). EEG was sampled at a resolution of 250Hz
and band passed at 100Hz.

Vigilance state scoring
Ongoing vigilance was determined by assessment of EEG records in part by the
software SleepSign for Animals (KESSEI COMTEC CO.) Each EEG record was binned
in 8 second epochs and then screened using the following thresholding parameters:
high EMG integral to detect wake (W), high FFT delta_power to detect non-rapid-eye
movement sleep (NR), and high FFT theta_ratio to detect rapid-eye-movement sleep
(REM). Resulting analysis (~90% accurate) was then confirmed by an expert in
vigilance-state scoring who visualized each 8s epoch to determine the sate based on
the following parameters: W was determined by high frequency and low amplitude EEG
activity accompanied by high EMG activity, NR by low frequency and high amplitude
EEG activity with little to no EMG activity, and REM by high frequency and low
amplitude EEG activity with no EMG activity. Epochs with non-gaussian waveform were
discarded as artifact. No file contained more than 1% artifact.

24 hour baseline electroencephalographic assessment
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EEG recordings were made after habituation in chambers as described above.
Spectrograms were generated from text files using a custom script for MATLAB. To plot
relative power in frequency ranges from 0-30Hz, variance was reduced amongst
surgical implants by normalization to the average from 0-100Hz within animal for a
given analysis period (24 hours, ZT 12-0, and ZT 12-24). To plot vigilance state
dependent relative power, data was normalized within animal to the average power from
0-100Hz of the vigilance state being assessed (W, NR, or R). Amount of time spent in
each vigilance state is expressed as a percent of the total analysis time (24 hours, ZT
12-0, and ZT 12-24). A bout is defined as contiguous epochs scored as the same
vigilance state while a transition is defined by a switch amongst ongoing vigilance state.

Behavioral measures
For activity analysis, diurnally entrained mice were individually housed in
metabolic activity chambers allowing for measurement of activity by beam break.
Activity was measured for a total of 28 days. For the first 14 days mice where kept
under diurnal conditions. On day 15 through day 28 mice were housed under constant
darkness conditions to measure free running circadian rhythmicity. Visual placement
tasks were created using the modified SHIRPA protocol. For sleep deprivation (SD)
measures, mice underwent EEG/EMG surgery and were allowed to recover as
described above. Prior to experimental recordings animals were habituated to recording
chambers for 48 hours (days 1 & 2) as described above. Baseline recordings began at
zeitgeber time (ZT) 0 (0700/light onset) on the third day and ended at ZT 0 on the fourth
day. Beginning at ZT 0 on the fourth day animals underwent SD for 24 hours using the
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gentile handling method. As previously described71 gentile handling protocols were
initiated when animals began to display a sleeping posture (no movement and lowered
head). Gentile handling procedures induced sleep disruption by introduction of novel
objects, tapping on the cage, or gentile touch with an inflated surgical glove. These
procedures were used to reduce stress caused by directly touching the animals. The
recovery period began with cessation of SD procedures at ZT 0 on the fifth day.
Recovery recordings were made for a total of 24 hours (day 5) allowing for sleep ad
libitum. A simplified timeline is provided below. Data was scored for vigilance states as
described above.

Sleep deprivation experimental timeline

Statistical analyses
Statistical analyses were performed using SigmaPlot 12.5 software. Differences
amongst cFFT plots, vigilance state percent time analysis, and transition assessment
were determined by within-subject repeated measure two-way ANOVA. Total transitions
during the ZT 0-12 and ZT 12-24 were assessed by one-way ANOVA. Significant main
effects and interactions were further examined using Bonferroni t-test post hoc analysis.
The significance threshold for all test was set at 0.05.
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CHAPTER 4
EXPERIMENTAL HYPOTHESES
1. To test the hypothesis that reduced α2 signaling at the AIS will impact
baseline electroencephalographic activity. Evidence suggests α2 signaling at
the AIS is central to the patterning of excitatory pyramidal output into oscillatory
states. cFFT and spectral assessment of 24 hour EEG recordings will allow for
the determination of the impact of a loss of α2 at the AIS to the generation of
specific oscillatory states which can be correlated to behavioral states.

2. To test the hypothesis that reduced α2 signaling at the AIS will result in
abnormal sleep architecture. Sleep homeostasis depends on integration of
neuronal networks across CNS regions. Given the localization of α2 at the AIS
allowing for modulation of AP initiation, we suspect a reduction in expression will
disrupt homeostatic progression of sleep. Sleep scoring of 24 hour EEG
recordings will allow for the analysis of sleep architecture across the circadian
cycle.

3. To test the hypothesis that reduced α2 signaling at the AIS will alter
homeostatic response to sleep challenges. Finally, if α2 contributes to the
homeostatic regulation of sleep as suspected, we expect to find an altered
homeostatic response to sleep challenges. Light and sleep deprivation will allow
us to test this at the level of the circadian rhythm and homeostatic regulation of
sleep pressure.
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CHAPTER 5
RESULTS
Reduced α2 signaling at the axon initial segment increases baseline
electroencephalographic power across a 24 Hour period
Previous analysis of EEG recordings made in adult Gabra2-1 homozygous mice
revealed an increase of power in the delta frequency range (0.5-4Hz) over the course of
a short recording period35. Given this, our first goal was to elucidate if the observed
increase of delta power in Gabra2-1 homozygous mice is present throughout the
sleep/wake cycle. To answer this question, we examined a 24 hour period of continuous
EEG recordings made from freely moving wildtype, Gabra2-1 heterozygous, and
homozygous mice. Qualitative spectrograms representing individual 24 hour baseline
EEG records (Figure 2 A-C) suggested that Gabra2-1 homozygous mice have
increased power in low frequency ranges. To assess this quantitatively, we applied a
cFFT to the EEG data allowing us to plot relative power in frequencies ranging from 030Hz for the entire 24 hour recording period (Figure 2 D). While the Gabra2-1
heterozygous mice had significantly increased power when compared to wildtype
controls in a very limited set of frequencies (genotype x time interaction P = <0.01;
Bonferroni post hoc p ≤ 0.05 from 3.4-3.9Hz), the homozygous mice displayed
significantly increased power in a broader range of frequencies from 0.48-6.3Hz
(genotype x time interaction <0.01; Bonferroni post hoc p ≤ 0.05 from 3.4-3.9Hz),
covering all of the delta frequency band and low end theta. Low frequency oscillations
are associated with sleep4,82, so next we examined if the increased delta power in
Gabra2-1 homozygous mice follows circadian patterning with respect to

21

Figure 1. Generation and characterization of the Gabra2-1 mutant mouse model basic phenotype.
A. Cartoon depicting the large intercellular loop spanning transmembranes 3 and 4 of GABA type A
receptor in which amino acid residues 358-375 of the α2 loop are replaced with the corresponding
sequence from the α1 loop reducing collybistins affinity for the mutant receptor. B. Cortical extracts
from wildtype, Gabra2-1 heterozygous, and homozygous mice were subjected to western blotting with
antibodies raised against α2 c-terminus, collybisitin (CB), and internal control actin. C. Adult wildtype,
Gabra2-1 heterozygous, and homozygous mice frontal cortex sections subjected to
immunohistochemistry with antibodies raised against neurofascin to visualized the axon initial
segment and VGAT to visualize inhibitory presynaptic markers (top overlay; bottom VGAT only)

photoentrainment. To answer this question, we next plotted cFFT’s of the 24 hour EEG
recordings parsed with respect to the circadian time periods (Figure 2 E & F). The EEG
recordings were made from mice entrained to a 12 hour light cycle (0700/lights on), and
as such, subjective night (lights on) is defined as zeitgeber time (ZT) 0-12 and
subjective day (1900/lights off) as ZT12-24. This analysis revealed the Gabra2-1
homozygous mice had increased power in low end frequencies over the wildtype
controls irrespective of the circadian time period (for hourly assessment of absolute
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Figure 2. Increased power in Gabra2-1 homozygous mice is persistent across a 24 hour period.
A-C. Representative spectrograms (top) and raw traces (bottom) of 24 hour electroencephalographic
(EEG) recordings made in freely moving wildtype (A), heterozygous (B), and homozygous (C) Gabra21 mice. Zeitgeber time (ZT) 0-12 is the light period (0700-1900) while ZT 12-24 is the dark period
(1900-0700) indicated by the grey bar. D. A cumulative fast Fourier transformation (cFFT) applied to
24 hours EEG data shows increased power in Gabra2-1 homozygous (LS mean 287.789 ± 7.838)
over wildtype (LS mean 258.869 ± 7.838) in low frequencies (LS mean het – 271.731 ± 7.011;
genotype x frequency interaction <0.001). E & F. cFFTs of 24 hour EEG recordings parsed into ZT 012 (E; LS means; WT – 245.618 ± 7.604; het – 264.703 ± 6.801; homo – 288.289 ± 7.604; genotype x
frequency interaction <0.001) and ZT 12-24 (D; LS Means; WT – 269.787 ± 7.901; het – 278.293 ±
7.067; homo – 289.630 ± 7.901; genotype x frequency interaction p = <0.001) suggests increased
power in Gabra2-1 homozygous mice is maintained across subjective day and night. n = 4 to 5 per
genotype, values listed are mean ± standard error, p values from repeated measures ANOVA, post
hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001.
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delta power see SI Figure 2). These observations demonstrate that Gabra2-1
homozygous mice have persistently increased delta power across the 24 hour period.
Collectively, these initial analyses suggested Gabra2-1 heterozygous mice have similar
power to wildtype controls while homozygous mice have a persistent increase in delta
that is not impacted by salient circadian cues.

Electroencephalographic alterations in Gabra2-1 homozygous mice are vigilance state
specific
Given that we did not observe circadian specific alterations in delta power in
Gabra2-1 mice, we next wished to examine if these alterations were vigilance state
specific as delta frequencies are a necessary component of NR sleep83. To explore
vigilance specificity of the EEG power alterations, we next scored each 8 second epoch
of EEG data as corresponding to a state of wake (W), non-rapid-eye-movement sleep
(NR), or rapid-eye-movement sleep (R) determined by the characteristics and
relationship amongst the EEG/EMG signal for the given epoch (Materials & Methods).
Qualitative visualization of raw traces of each vigilance state type (Figure 3 A)
suggested Gabra2-1 animals may have altered spectral characteristics in each of these
states. To test this observation, we plotted cFFT’s of the EEG data from 0-30Hz with
respect to vigilance state (Figure 3 B-D). Strikingly the homozygous mice displayed
increased power in limited yet distinct frequency ranges for each vigilance type. To
determine the specific frequency ranges impacted, we next parsed the data into relative
frequency bands and plotted with respect to the vigilance state (Figure 3 E-G).
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Figure 3. Gabra2-1 homozygous mice have increased electroencephalographic power in the state of
wake and non-rapid-eye-movement sleep restricted to specific frequency ranges.
A. 4 second representative electroencephalographic (EEG) and electromyographic traces from
wildtype, heterozygous, and homozygous Gabra2-1 mice scored as a state of wake (W), non-rapideye-movement sleep (NR), or rapid-eye-movement sleep (R). B-D. Cumulative fast Fourier
transformation (cFFT) of 24 hours EEG data parsed with respect to vigilance state reveals the power
structure of epochs scored as W (B; LS means; WT – 214.339 ± 10.684; het – 243.179 ± 9.556;
homo – 254.766 ± 10.684; genotype x frequency interaction p <0.001), NR (C; LS means; WT –
287.847 ± 5.098; het – 291.478 ± 4.560; homo 306.632 ± 5.098; genotype x frequency interaction P
<0.001), or R (D; LS means; WT – 234.160 ± 10.084; het – 242.182 ± 9.020; homo – 263.739 ±
10.084; genotype x frequency interaction p = 0.007). E-G. Spectral analysis of EEG data parsed
with respect to vigilance state for a 24 hour period demonstrates Gabra2–1 homozygous mice have
increased δ power (0.4-5Hz) restricted to the state of NR (E; LS means; WT – 550.896 ± 52.403; het
– 592.037 ± 46.871; homo – 696.291 ± 52.403) and decreased γ power restricted to the state of W
(G; WT – 29.580 ± 3.671; het – 24.656 ±3.283; homo 17.291 ± 3.671) while other relevant frequency
bands including theta (F; WT – 417.148 ± 2.899; het – 428.276 ± 18.692; homo – 504.932 ±20.899)
are non-significant when compared to controls (for normalization variations see supplemental figure
3). n = 4 to 5 per genotype, values listed are mean ± standard error, p values from repeated
measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001.
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Frequency band ranges in this study are defined as follows: delta (0.5-4 Hz), theta (4-12
Hz), alpha (12-18 Hz), beta 18-30 Hz), and gamma (30-100 Hz). This analysis allowed
us to discover that the Gabra2-1 homozygous mice had increased power in the delta
frequency ranges restricted to the state of NR (Figure 3 E) accompanied by a by a
decrease in gamma power restricted to periods of W (Figure 3 G; for spectral analysis
of vigilance states when normalized to all band variations see SI Figure 3). More
broadly, these findings suggest that Gabra2-1 homozygous mice have altered EEG
power during both wake and sleep, but that these alterations are restricted to specific
frequencies.

Gabra2-1 mice spend more time awake during the subjective night
In light of the observation that Gabra2-1 homozygous mice had increased delta
power restricted to the state of NR we hypothesized that they would have altered
structural organization of sleep, or sleep architecture. To test this hypothesis, we
individually housed diurnally entrained mice in metabolic activity chambers in which
activity is chronically measured by beam break. Over the course of 14 days we
observed an increase in Gabra2-1 homozygous activity during ZT 0-12 (Figure 4 A-B).
In addition, we observed a sharp increase in activity one-hour post and prior to the
day/night transition (Figure 4 C). Activity can act as a proxy for wakefulness thus these
data suggests Gabra2-1 homozygous mice have increased time awake during ZT 0-12
(subjective night). Activity based assessment is limited by the fact that it cannot detect
subtle vigilance states such as quiet wakefulness, when the mouse is awake but not
moving. To mitigate this confound we next examined EEG records, the ‘gold standard’
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for determining ongoing vigilance99. Subsequent examination of data scored for

***

***
***

vigilance (Materials & Methods) reveled the percent time animals spent in each

*

*
***
*

Figure 4. Gabra2-1 homozygous spend more time
awake during subjective night.
A. 24 hour plot representing 14 days activity from
diurnally entrained wildtype, and homozygous
Gabra2-1 mice individually housed in metabolic
activity chambers under diurnal conditions. B.
Assessment of total activity during zeitgeber time
(ZT) 0-12 (subjective night). C. Assessment of total
activity during ZT 1 and ZT 24. D & E. Analysis of
percent (%) time spent in a state of wake (W) (D; LS
means; WT – 51.281 ± 1.760; het – 48.419 ± 1.574;
homo – 53.747 ± 1.760), or rapid-eye-movement
sleep (R) (E; LS means; WT – 4.886 ± 0.283; het –
4.470 ± 0.253; homo – 3.923 ± 0.283) over 24
hours, ZT 0-12, or ZT 12-24 demonstrates Gabra21 homozygous mice spend more time awake during
subjective night (NR represented in supplemental
figure 4). F. Ratio of theta/delta power binned every
15 minutes to examine regulation of frequency
bands associated with vigilance state transitions (LS
means; WT – 0.853 ± 0.0690; het – 0.824 ± 0.0617;
homo – 1.061 ± 0.0691; genotype x frequency
interaction p = 0.012). n = 4 to 5 per genotype,
values listed are mean ± standard error, p values
from one way ANOVA or repeated measures
ANOVA, post hoc Bonferroni, * = ≤0.05, ** = ≤
0.005, *** = <0.001.
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vigilance state across ZT 0-12 and ZT 12-24 (Figure 4 D & E) is altered, again suggest
disrupted sleep architecture in Gabra2-1 homozygous mice. Specifically, the EEG
assessment revealed Gabra2-1 heterozygous and homozygous mice spend similar
amounts of time in each vigilance state across the 24 hour period, yet the homozygous
mice spend significantly more time awake during subjective night (Figure 4 D ZT 0-12)
at the expense of time in R (Figure 4 E ZT 0-12). Further, this observation is restricted
to subjective night as Gabra2-1 animals spend similar time in each vigilance state
during subjective day (Figure 4 D & F; ZT 12-24; NR represented in SI figure 4).
Driven by our observations that Gabra2-1 homozygous mice have reduced sleep
restricted to subjective night we next wished to examine biological indicators of
appropriate vigilance regulation. While prominent delta power is associated with NR
sleep, high theta frequencies are associated with wake and transitioning amongst these
states82,85. To understand the ongoing relationship amongst these signals modulating
vigilance and transitioning in the mice, we next plotted a ratio of theta to delta
frequencies when binned every 15 minutes over a 24 hour period (Figure 4 F). This
analysis suggested that Gabra2-1 homozygous mice do not regulate the relationship
amongst these behaviorally relevant frequency ranges in the same way as the wildtype
littermates, with aberration appearing around the transition from subjective day to night
(Figure 4 F). To confirm these findings are not an artifact of an inability to detect
photoperiods due to visual impairment, two visual placement task from the modified
SHIRPA screening protocols (http://empress.har.mrc.ac.uk/browse/?sop_id = 10_002_0)
were preformed (Materials & Methods) demonstrating normal vision in both
heterozygous and homozygous Gabra2-1 mice (SI table 1). These findings suggest
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Gabra2-1 homozygous mice have altered sleep architecture during subjective night that
may be driven by dysregulation of global brain states.
Gabra2-1 have deficits in vigilance state transitions restricted to subjective night
Encouraged by our observations of decreased time asleep during subjective
night and deficits in regulation of brain states associated with vigilance state
transitioning in Gabra2-1 homozygous mice, we next wished to examine vigilance state
duration and transitions across a 24 hour period. These measures are indicators of
sleep quality as they are disrupted when the suprachiasmatic nuclei is lesioned86 or
when animals are housed under continuous bright light87. Qualitative examination of 24
hour actograms (Figure 5 A) suggested altered vigilance state bout duration (time
between transitions) and total transitions (vigilance shift from W to NR, NR to W, NR to
R, or R to NR.) To quantitatively assess this observation, we determined the mean bout
duration of W, NR, and R with respect to subjective day and night (Figure 5 B & C).
These data show a striking increase in mean bout duration of W in Gabra2-1
homozygous mice during subjective night (Figure 5 B) which is not present during
subjective day (Figure 5 C). To corroborate these data we next plotted the total number
of transitions occurring over 24 hours (SI Figure 4), and within ZT 0-12 and ZT 12-24
(Figure 5 D & E) as we would expect decreased transitions to accompany an increase
in mean bout duration. These data show Gabra2-1 homozygous mice have decreased
total transitions over 24 hours (SI Figure 4), yet these deficits are restricted to subjective
night (Figure 5 D & E). To further clarify the microarchitecture of the observed deficits in
transitioning during the light phase we next examined the number of transitions
occurring during ZT 0-12 and ZT 12-24 by transition type (Figure 5 F & G). This analysis
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Figure 5. Gabra2-1 homozygous have increased vigilance state duration and decreased transitions
restricted to subjective night.
A. Representative hypnograms of 24 hour electroencephalographic (EEG) recordings parsed into 8
second epochs and scored as a state of wake (W), non-rapid-eye-movement sleep (NR), or rapid-eyemovement sleep (R) from wildtype, heterozygous, and homozygous Gabra2-1 mice. B & C. Mean
duration of vigilance state bout scored as W, NR, or R for zeitgeber time (ZT) 0-12 (B; LS means; WT
– 360.333 ± 40.046; het – 429.800 ± 35.818; homo – 524.333 ±40.046) and ZT 12-24 (C; LS means
WT – 769.167 ± 170.414; het 828.867 ± 152.423; homo 832.583 ± 170.414). D & E. Summation of all
vigilance state transition types for ZT 0-12 (D; LS means; WT – 202.000 ± 10.840; het – 171.600 ±
4.366; homo – 155.500 ± 10.82) and ZT 12-24 (E; LS means; WT – 63.000 ± 7.141; het 57.400 ±
3.868; homo – 61.250 ± 11.643) shows an overall deficit in Gabra2-1 homozygous mice transitions
during the light phase. F & G. Examination of transitions by type during ZT 12-0 (F; LS means; WT –
34.750 ± 3.705; het – 33.920 ± 3.314; homo 23.563 ± 3.705) and ZT 12-24 (G; LS means; WT –
15.750 ± 1.991; het – 14.350 ± 1.781; homo – 15.313 ± 1.991). n = 4 to 5 per genotype, values listed
are mean ± standard error, p values from one way ANOVA or repeated measures ANOVA, post hoc
Bonferroni, * = ≤0.05, ** = ≤0.005, *** = <0.001.
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supported our findings that transitioning is reduced during subjective night and revealed
that this reduction is specific to the transition into and out of R (Figure 5 F). Taken
together, our findings demonstrate that the Gabra2-1 homozygous mice have reduced
time asleep during subjective night that is manifested as a reduction in behavioral
transitions during sleep, specifically when transitioning into and out of NR sleep.

Gabra2-1 mice cannot maintain free running circadian rhythmicity and have attenuated
response to sleep deprivation.
Next, we undertook two experiments, each introducing a sleep challenge, to
determine the homeostatic sleep response of Gabra2-1 mice. In the first experiment we
individually housed diurnally entrained mice in metabolic activity chambers allowing for
the chronic tracking of movement by beam break. Initially baseline activity was
monitored under diurnal conditions (L/D; Figure 6 A top actograms) for 14 days followed
by the introduction of constant darkness (D/D; Figure 6 A bottom actograms) for 14
days. Qualitative assessment suggests the wildtype group maintained a free running
circadian rhythm for the entirety of the D/D portion of the experiment88 while the
Gabra2-1 homozygous mice displayed an aberrant increase in activity on the first light
period in which darkness was introduced (Figure 6 A bottom right actogram). A
quantitative comparison of total activity during subjective night under L/D and D/D
conditions (Figure 6 B) demonstrated the loss of light, the most salient environmental
zeitgeber, causes a significant increase in activity in Gabra2-1 homozygous mice during
ZT 0-12. Encouraged by our findings that Gabra2-1 homozygous mice are unable to
maintain a free running circadian rhythm in the absence of light, we next set out to
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examine how these animals would respond to a severe sleep challenge such as total
sleep deprivation (SD). To determine the homeostatic response to sleep loss, we
recorded EEG while inducing SD by gentile handling methods for a total of 24 hours
(Materials & Methods; timeline Figure 6 C; representative spectrograms Figure 6 D). On
the day of 24 hours sleep deprivation Gabra2-1 mice had a similar response to the
procedures as the wildtype group, maintaining a state of W for ~95% of the time (Figure
6 E), yet had a very different homeostatic response on the recovery day. Analysis of
percent time pre/post sleep deprivation reveal an expected decrease in time spent
awake in the wildtype group which is compensated for by an increase in time spent in
the stage of NR and R (Figure F G; pre/post SD x vigilance state interaction p = 0.002)
while both Gabra2-1 heterozygous and homozygous show no significant changes
(Figure 6 G & H). Taken together these findings demonstrate Gabra2-1 homozygous
mice have an inability to homeostatically respond to sleep challenges.
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Figure 6. Gabra2-1 homozygous mice have altered behavioral response to sleep challenges.
A. Representative actograms of 24 hours activity under diurnal (L/D; top trace) and total darkness
conditions (D/D; bottom trace) from wildtype (left) and Gabra2-1 homozygous (right) mice. B.
Comparison of total activity under diurnal conditions (grey bars) and constant darkness. C.
Comparison of activity ratio under diurnal conditions (grey bars) and constant darkness. D. Sleep
deprivation (SD) timeline. E. Representative wildtype spectrograms from each day of SD experiment.
F. Quantification of percent time spent in a state of wake (W) or non-rapid-eye-movement sleep (NR)
representing 24 hours of SD. G-I. Quantification of percent time spend in a state of W, NR, or rapideye-movement sleep (R) pre and post SD for wildtype (G; LS means; W – 52.383 ± 3.893; NR –
42.800 ± 3.893; R – 4.788 ± 3.893), heterozygous (H; LS means; W 57.879 ± 3.578; NR – 37.500 ±
3.578; R – 4.621 ± 3.578), and Gabra2-1 homozygous mice (I; LS means; W – 51.112 ± 1.817; NR –
44.613 ± 1.817; R – 4.272 ± 1.817). SD data n = 2 per genotype; values listed are mean ± standard
error; p values from repeated measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** =
<0.001.
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CHAPTER 6
DISSCUSSION AND FUTURE DIRECTIONS
Despite the significant role of GABAARs containing the α2 subunit found at the
AIS at controlling excitatory output, little is known about the behavioral impact of its loss.
Here we report reduced α2 signaling at the AIS results in a drastic increase in baseline
EEG delta power in Gabra2-1 homozygous mice. This finding extends previous
observations of increased delta power in Gabra2-1 homozygous mice to a longer time
scale (24 hours) as previous recordings were 1hr in duration and made while the
animals were awake. In addition, by utilizing longer recording times we were able to
discover that the increase in baseline delta power is not modulated with respect to the
animal’s circadian period. These findings suggest Gabra2-1 homozygous mice have
altered brain wide processing.
Given the Gabra2-1 mouse model displayed an increase in delta frequencies
which are predominate during the state of NR sleep, we next wished to parse out the
specific impact of loss of α2 signaling at the AIS on sleep and sleep quality.
Examination of 24 hour EEG recordings revealed the increased delta power observed in
Gabra2-1 homozygous mice is restricted to the state of NR sleep while decreased
gamma power is observed during the state of W. Although further measures are needed
to determine the behavioral impact of reduced gamma power in Gabra2-1 homozygous
mice during W, gamma power is associated with active learning and memory7,89.
Further, altered gamma frequencies are often observed in psychiatric disorders and
neurodevelopmental disorders90–92. In addition, high frequencies (30-100Hz) have been
demonstrated to be dependent upon the activity of GABAARs found at inhibitory
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synaptic sites93. Given this, our observation of the Gabra2-1 mouse model suggests
gamma frequencies during the state of W may depend upon α2 signaling at the AIS.
Delta power is modulated by prior activity with extended wakefulness resulting in
increased delta power71. As such, high delta during NR sleep is associated with high
levels of sleep pressure69. Our data demonstrate Gabra2-1 homozygous mice have
increased delta power restricted to the state of NR indicating they have a high level of
baseline sleep pressure. Interestingly, high sleep pressure (delta) does not correlate to
good sleep quality as people with Rett’s syndrome, who demonstrate continuous high
delta activity, have been shown to have poor sleep efficiency94.
Because we detected several baseline measures altered that are associated with
sleep and sleep quality, we next examined the distribution of vigilance in the Gabra2-1
mice across an entire circadian cycle. We observed a similar amount of time spend in a
state of W, NR, or R when examining the 24 hour period, yet when parsed by subjective
day and night we find altered distribution of these states. Specifically, we find an
increase in time spend awake during subjective night. Further, we found dysregulation
amongst the relationship between delta and theta frequencies occurring primarily 2
hours before and after the day/night transition. Data from the human population
suggests sleep onset is depended on the reduction of high frequency’s associated with
wakefulness (beta, alpha, gamma) and an increase in the low frequencies associated
with sleep (delta and theta)95. Therefore, the dysregulation of delta to theta observed in
Gabra2-1 homozygous may be mechanistic in our findings that they have difficulty
patterning vigilance around the circadian cycle. These data suggest the observed
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baseline EEG alterations have a significant impact on the homeostatic progression of
sleep in Gabra2-1 mice.
Having established an increase in time spent awake during subjective night along
with an indication of poor regulation of vigilance state transitions (dysregulated
delta/theta) in Gabra2-1 homozygous mice, we next set out to examine vigilance state
transitions across the 24 hour period. When examining all vigilance state transition
types (W to NR, NR to W, NR to R, and NR to R) we report an overall deficit in vigilance
state transitioning in Gabra2-1 homozygous mice that is restricted to subjective night.
Further, when parsed by transition type, we find the deficit in transitioning is restricted to
the transitions from NR sleep into R sleep or from R sleep back into NR sleep (NR-RNR). The NR-R-NR transitions are a relatively well described process that depend on
inhibition or disinhibition at appropriate times of several brain regions including the
pontine nuclei96,97. Of note, the pontine nuclei is found to be highly enriched with α220. In
addition, in humans it has been demonstrated that the onset of REM sleep is preceded
by a decrease in delta and theta power and the inverse is true for its offset98. Our data
suggests reduced α2 at the AIS increases baseline delta power, altering the relationship
amongst the delta and theta frequencies and as such may contribute to the observed
difficulty in the NR-R-NR transition.
Having established baseline alterations in Gabra2-1 homozygous EEG activity,
vigilance state patterning, and vigilance state transitioning, we set out to confirm these
observations by introducing sleep challenges. It is well known that some sleep disorders
are associated with difficulty maintaining circadian rhythmicity and coping with
challenges to sleep99,100. Thus, if the Gabra2-1 mice are having difficulty with sleep
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patterning, we would expect to see an altered homeostatic response to sleep
challenges. Here we report a deficit in Gabra2-1 homozygous mice ability to maintain a
circadian rhythm in the absences of the salient environmental zeitgeber light. This deficit
may be considered severe as we observed a loss of rhythmicity in a brief period of time
(1 to 2 days of constant darkness) while the wildtype mice maintained a free running
rhythm for the entirety of the experiment. Further supporting our findings of sleep
deficits in Gabra2-1 homozygous mice, here we report an attenuated homoeostatic
response to SD. As mentioned above, it is a well-known phenomenon that sleep
pressure is dependent upon prior activity thus, SD increases sleep pressure69,71. Given
Gabra2-1 homozygous mice underwent SD similar to wildtype controls (~95% W of 24
hours SD) it is striking to report an inability of these mice to homeostatically alter
vigilance state patterning (increase time asleep) as little to no change occurred in
response to SD. These data taken together demonstrate the Gabra2-1 homozygous
mice have difficulty homeostatically responding to sleep challenges and support our
claims of baseline homeostatic dysregulation.
In conclusion, our findings reveal the role of GABAA receptors containing the α2
subunit found enriched at the AIS postsynaptic to chandelier cells to the establishment,
maintenance, and quality of sleep. We demonstrate that a loss of GABAergic signaling
at the AIS results in an overall increase in EEG delta frequencies that are maintained
across the circadian cycle. We find this increase in delta power is accompanied by
alterations to vigilance state patterning, specifically, a reduction in time asleep during
subjective night. Lastly, we report an altered response to two different sleep challenges
in Gabra2-1 mice, supporting our findings of poor-quality baseline sleep. These data
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begin to shed light on the molecular mechanisms of common sleep disturbances
observed in humans known to have altered GABAergic. Further these data will provide
insight for the development of targeted sleep therapeutics.
To conclude this project, we are currently undertaking experiments using IHC to
examine GABAARs containing the α2 subunit in the tuberomammillary nucleus of
Gabra2-1 mice. The tuberomammillary nucleus houses histaminergic neurons that are
active during W and inactive during states of sleep. GABAergic neurons projecting from
the preoptic nucleus drive this sleep wake profile of histaminergic neurons. We suspect
a reduction of α2 receptors in the tuberomammillary nucleus may be mechanistic to the
homeostatic dysregulation of sleep observed in Gabra2-1 mice.
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CHAPTER 7
SUPPLEMENTARY INFORMATION

Supplementary Figure 1. Generation and genotyping Gabra2-1 mice.

A. Cartoon schematic depicting the targeting vector used to insert amino acid residues 358-375 form
the large intercellular α1 loop into exon 10 of the α2 subunit. B. Representative polymerase change
reaction results for identification of wildtype littermate controls, Gabra2-1 heterozygous (het), and
Gabra2-1 homozygous (homo) mice.

Supplementary Figure 2. Hourly assessment of absolute delta power for a 24 hour period.
Summation of total power in frequencies from 0.5-4Hz hrouly for 24 hours suggests consistently
elevated power in Gabra2-1 homozygous mice across the circadian cycle (LS means; WT –
121571.135 ± 48565.020; het – 166484.957 ± 43437.874; homo – 287123.257 ± 48565.020) n = 4 to
5 per genotype; values listed are mean ± standard error; p values from repeated measures ANOVA,
post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001.
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Supplemental Figure 3. 24 hour cFFT normalized to delta, theta, and gamma.
A-C. Cumulative fast fourier transformation (cFFT) applied to 24 hours EEG data and normalized to
average δ power for 24 hour period (A), Zeitgeber time (ZT) 0-12 (B), and ZT 12-24 (C). D-F.
Cumulative fast Fourier transformation (cFFT) applied to 24 hours EEG data and normalized to
average θ power for 24 hour period (D), ZT 0-12 (E), and ZT 12-24 (F). G-I. Cumulative fast Fourier
transformation (cFFT) applied to 24 hours EEG data and normalized to average γ power for 24 hour
period (G), ZT 0-12 (H), and ZT 12-24 (I).
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Supplementary Figure 4. Assessment of percent time spent in state of non-rapid-eye-movement
sleep.
Values expressed as a percent of total analysis time (24 hours, zeitgeber time (ZT) 0-12, and ZT 1224). n = 4 to 5 per genotype; values listed are mean ± standard error; p values from repeated
measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001.

Supplementary Figure 5. Assessment of total transitions across a 24 hour period.
Summation of all transition types (W to NR, NR to W, NR to R, and R to NR) across a 24 hour period
demonstrates a significant reduction in Gabra2-1 homozygous mice vigilance state transitioning. n = 4
to 5 per genotype; values listed are mean ± standard error; p values from one way ANOVA, post hoc
Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001.
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Supplementary Table 1. Results for two visual tests from modified SHIRPA screening protocols.
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